Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc has a current enterprise value of approximately $430 million, positioning it for significant long-term growth potential, particularly with a successful partnership with Novopro that could yield 8-10 times the current share price. The company's innovative drug candidates, notably SEP-786 and SEP-631, show promising results in preclinical trials, suggesting improved efficiency in clinical execution and the potential to rival established therapies like Xolair, which generated nearly $3.9 billion in sales in 2023. As Septerna advances its pipeline in key therapeutic areas, including endocrinology and immunology, the positive data surrounding its drug candidates enhances the firm's outlook and underscores the viability of its proprietary Native Complex Platform in the GPCR space.

Bears say

The financial outlook for Septerna Inc is hindered by several significant risks, primarily centered around potential delays in the advancement of its clinical candidates, specifically SEP-631, which could impact overall development timelines. Additionally, setbacks in clinical trials and challenges in securing necessary approvals for key products pose critical threats to the company’s future revenue prospects. Furthermore, the uncertainty surrounding its partnership with Novo Nordisk, coupled with risks of lower-than-expected market penetration rates and the potential for long-term dilution, further complicates the company's financial position.

Septerna Inc (SEPN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.